Pharmafile Logo

Health Behaviour Change

- PMLiVE

GSK takes severe asthma antibody into phase III

Mepolizumab could help patients who cannot prevent attacks using current therapies

Under threat: The pharma industry in Spain

The Eurozone crisis threatens healthcare and pharma opportunities

- PMLiVE

More action needed to prevent AF-related strokes

Bayer-sponsored report says Europe is heading for a ‘stroke crisis’

- PMLiVE

Sir Christopher Gent ‘stepping down’ as GSK chair

He will leave the pharma firm in the next two or three years, according to a UK press report

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

- PMLiVE

Guide to gamification

How to execute digital: Using gaming as part of a pharma marketing campaign

- PMLiVE

Incite strengthens its healthcare team

Emily Peasgood joins agency as principal

- PMLiVE

Atlantis Healthcare Group bring in new UK MD

Charles MacKinnon will take over from Kate Reid

- PMLiVE

Dare to be Different

As R&D struggles to deliver and generic competition soars, the opportunity to differentiate your brand has never been more crucial. But how you do it? Our author, an expert on...

- PMLiVE

Boehringer-Lilly win expanded European licence for Trajenta

Type 2 diabetes drug approved as add-on to insulin in adults

- PMLiVE

GSK, Pfizer and Shionogi rewrite HIV joint venture terms

Comes ahead of first regulatory submissions for lead drug candidate dolutegravir

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links